These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3154680)

  • 1. The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication).
    Eliahou HE; Cohen D; Ben-David A; Herzog D; Serban I; Gavendo S; Kapuler S; Kogan N; Hellberg B
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):523-8. PubMed ID: 3154680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man.
    Eliahou HE; Cohen D; Hellberg B; Ben-David A; Herzog D; Shechter P; Kapuler S; Kogan N
    Am J Nephrol; 1988; 8(4):285-90. PubMed ID: 3189422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blocker nisoldipine in chronic renal failure.
    Blau A; Herzog D; Shechter P; Sachs D; Eliahou HE
    Ren Fail; 1990; 12(2):113-9. PubMed ID: 2236726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
    N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nisoldipine--a new calcium channel blocker for hypertension.
    Med Lett Drugs Ther; 1996 Feb; 38(968):13-4. PubMed ID: 8592476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The control of hypertension and its effect on renal function in rat remnant kidney.
    Eliahou HE; Cohen D; Herzog D; Shechter P; Serban I; Kapuler S; Schiby G; Gavendo S
    Nephrol Dial Transplant; 1988; 3(1):38-44. PubMed ID: 3132638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.
    Tarnow L; Sato A; Ali S; Rossing P; Nielsen FS; Parving HH
    Diabetes Care; 1999 Mar; 22(3):491-4. PubMed ID: 10097934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment.
    Wilson J; Wahbha MM; Martin PG; Hainsworth R; Brownjohn AM; Turney JH; Davies JA; Prentice CR
    Eur J Clin Pharmacol; 1989; 37(5):437-41. PubMed ID: 2689184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
    Pepine CJ; Cooper-DeHoff RM; Weiss RJ; Koren M; Bittar N; Thadani U; Minkwitz MC; Michelson EL; Hutchinson HG;
    Am J Cardiol; 2003 Feb; 91(3):274-9. PubMed ID: 12565082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure.
    Barjon JN; Rouleau JL; Bichet D; Juneau C; De Champlain J
    J Am Coll Cardiol; 1987 Mar; 9(3):622-30. PubMed ID: 2880884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
    Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
    Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
    Wambach G; Breuer G; Kaufmann W
    Arzneimittelforschung; 1984; 34(5):620-3. PubMed ID: 6540581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy.
    Sørensen VB; Rossing P; Tarnow L; Parving H; Nørgaard T; Kastrup J
    Clin Sci (Lond); 1998 Dec; 95(6):709-17. PubMed ID: 9831696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid development of tolerance to the antihypertensive effect of nisoldipine.
    Ramsay LE; Waller PC
    J Hum Hypertens; 1988 Mar; 1(4):277-80. PubMed ID: 3065506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of the calcium antagonist nisoldipine in hypertensive non-insulin-dependent diabetic patients.
    Odigwe CO; McCulloch AJ; Williams DO; Tunbridge WM
    Diabet Med; 1986; 3(5):463-7. PubMed ID: 2951198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.
    White WB; Mansoor GA; Pickering TG; Vidt DG; Hutchinson HG; Johnson RB; Noveck R
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):806-14. PubMed ID: 10480474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjects.
    Laederach K; Weidmann P; Lauener F; Gerber A; Ziegler WH
    J Cardiovasc Pharmacol; 1986; 8(2):294-302. PubMed ID: 2422467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.